Animal-Assisted Visitation Program Chlorhexidine Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

July 15, 2025

Study Completion Date

July 15, 2025

Conditions
Methicillin-resistant Staphylococcus AureusClostridium DifficilePseudomonas Aeruginosa
Interventions
DRUG

Chlorhexidine

The goal of this work is to assess the effect of chlorhexidine (CHX)-based interventions--specifically use of pre-session chlorhexidine shampoo for the dog and use of chlorhexidine wipes on the dog's fur--on patient exposure to hospital-associated pathogens during the sessions with the dogs

Trial Locations (3)

19104

Children's Hospital of Philadelphia, Philadelphia

21205

Johns Hopkins, Baltimore

63110

Washington University in St. Louis, St Louis

All Listed Sponsors
collaborator

Children's Hospital of Philadelphia

OTHER

collaborator

University of Pennsylvania

OTHER

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Johns Hopkins Bloomberg School of Public Health

OTHER

NCT04171817 - Animal-Assisted Visitation Program Chlorhexidine Trial | Biotech Hunter | Biotech Hunter